Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 50 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MIRA Pharmaceuticals Inc | MIRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.8499 | 04:32:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8499 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 50 | - | 0.76 - 7.9799 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:02:02 | 50 | $ 0.8499 | USD |
MIRA Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 12.56M | 14.78M | - | 0 | -11.98M | -0.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MIRA Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MIRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.87 | 0.9171 | 0.815 | 0.8683066 | 15,614 | -0.0201 | -2.31% |
| 1 Month | 1.04 | 1.09 | 0.76 | 0.9199421 | 39,486 | -0.1901 | -18.28% |
| 3 Months | 1.13 | 1.84 | 0.76 | 1.49 | 630,561 | -0.2801 | -24.79% |
| 6 Months | 1.95 | 6.40 | 0.76 | 1.79 | 464,248 | -1.10 | -56.42% |
| 1 Year | 7.00 | 7.9799 | 0.76 | 2.11 | 340,294 | -6.15 | -87.86% |
| 3 Years | 7.00 | 7.9799 | 0.76 | 2.11 | 340,294 | -6.15 | -87.86% |
| 5 Years | 7.00 | 7.9799 | 0.76 | 2.11 | 340,294 | -6.15 | -87.86% |
MIRA Pharmaceuticals Description
| MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. |
